Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine

American Journal of Epidemiology

Volumn 182, Issue 12, 2015, Pages 977-979

  Khoury, Muin J ^a,b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

big data; epidemiology; funding; genomics; precision medicine; training

Indexed keywords

EPIDEMIOLOGY; GENOMICS; MEDICINE; TRAINING;

CONVERSATION; HUMAN; HUMAN EXPERIMENT; LEADERSHIP; EPIDEMIOLOGY; HEALTH CARE PLANNING; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PERSONALIZED MEDICINE; PROCEDURES;

BIOMEDICAL RESEARCH; EPIDEMIOLOGIC STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; PRECISION MEDICINE;

EID: 84950236486     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv228     Document Type: Review

References (16)

1. Khoury MJ, Wei G. The future of epidemiology in the era of precision medicine: cancer, cardiovascular disease, and beyond [Web log post]. http://epi.grants.cancer.gov/blog/archive/2015/08-11.html. Published August 11, 2015. Updated October 1, 2015. Accessed November 3, 2015.
2. Khoury MJ, Ioannidis JP. Big data meets public health. Science. 2014;346(6213):1054-1055.
3. Lauer MS. Time for a creative transformation of epidemiology in the United States. JAMA. 2012;308(17):1804-1805.
4. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-795.
5. Khoury MJ. Aprimer series on-omic technologies for the practice of epidemiology. Am J Epidemiol. 2014;180(2):127-128.
6. Mischak H, Critselis E, Hanash S, et al. Epidemiologic design and analysis for proteomic studies: a primer on-omic technologies. Am J Epidemiol. 2015;181(9):635-647.
7. Tzoulaki I, Ebbels TMD, Valdes A, et al. Design and analysis of metabolomics studies in epidemiologic research: a primer on-omic technologies. Am J Epidemiol. 2014;180(2):129-139.
8. Nair VS, Pritchard CC, Tewari M, et al. Design and analysis for studying microRNAs in human disease: a primer on-omic technologies. Am J Epidemiol. 2014;180(2):140-152.
9. Foxman B, Martin ET. Use of the microbiome in the practice of epidemiology: a primer on-omic technologies. Am J Epidemiol. 2015;182(1):1-8.
10. Coughlin SS. Toward a road map for global-omics: a primer on-omic technologies. Am J Epidemiol. 2014;180(12):1188-1195.
11. Brownson RC, Samet JM, Chavez GF, et al. Charting a future for epidemiologic training. Ann Epidemiol. 2015;25(6):458-465.
12. Vasan RS, Folsom AR. Invited commentary: future of population studies-defining research priorities and processes. Am J Epidemiol. 2015;181(6):369-371.
13. Keyes K, Galea S. What matters most: quantifying an epidemiology of consequence. Ann Epidemiol. 2015;25(5):305-311.
14. Kuller LH, Bracken MB, Ogino S, et al. The role of epidemiology in the era of molecular epidemiology and genomics: summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. Am J Epidemiol. 2013; 178(9):1350-1354.
15. Galea S. An argument for a consequentialist epidemiology. Am J Epidemiol. 2013;178(8):1185-1191.
16. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010;172(5):517-524.